this post is fantastic <a href="http://dermostyle.com/stmap_41irdoz.html?lamotrigine.astelin.alfuzosin.viagra" rel="nofollow">infinityhealthpharmacy.com</a>  And it&#8217;s Merrill&#8217;s marketing materials, much more than any action by Wing Chau, which are at the heart of the SEC&#8217;s case. The problem with Octans 1 is that a hedge fund called Magnetar had some control over its contents, and Magnetar&#8217;s role in helping to shape the contents of the CDO was not disclosed to investors. The SEC&#8217;s case rests wholly on the fact that the Octans 1 pitchbook and offering circular made no mention of &#8220;Magnetarâs rights in and influence over the collateral selection process&#8221;. This may or may not have been a felonious omission, but either way it&#8217;s hard to see how Wing Chau is really at fault.